Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023 [Yahoo! Finance]
Stevanato Group S.p.A. Ordinary Shares (STVN)
Company Research
Source: Yahoo! Finance
provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and full year 2023. Fourth Quarter and FY 2023 Highlights (compared with the same period last year) Revenue for the fourth quarter of 2023 increased 10% to €320.6 million, and high-value solutions represented 37% of total revenue. For the fourth quarter, diluted earnings per share were €0.17 and adjusted diluted earnings per share were €0.18. Adjusted EBITDA margin for the fourth quarter was 27%. For fiscal year 2023, revenue increased 10% to €1,085.4 million, and high-value solutions represented 34% of total revenue. For fiscal year 2023, diluted earnings per share were €0.55 and adjusted diluted earnings per share were €0.58. Adjusted EBITDA margin for fiscal year 2023 was 26.9%. The Company is establishing fiscal year 2024 guidance and expects revenue in the range of €1,
Show less
Read more
Impact Snapshot
Event Time:
STVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STVN alerts
High impacting Stevanato Group S.p.A. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
STVN
News
- Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024Business Wire
- Stevanato Group (STVN) to Report Q1 Results: What You Should Expect [Yahoo! Finance]Yahoo! Finance
- Stevanato Group S.p.A. (NYSE: STVN) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $30.00 price target on the stock.MarketBeat
- Stevanato Group S.p.A. (NYSE: STVN) is now covered by analysts at BNP Paribas. They set an "outperform" rating on the stock.MarketBeat
- Italy's Frugal Pharma Billionaire Eyes Place Among Global Leaders in Drug Injection Devices [BNN Bloomberg (Canada)]BNN Bloomberg
STVN
Earnings
- 3/7/24 - Miss
STVN
Sec Filings
- 3/27/24 - Form 6-K
- 3/26/24 - Form 6-K
- 3/25/24 - Form 6-K
- STVN's page on the SEC website